According to Novavax's latest financial reports the company's current EPS (TTM) is -$9.98. In 2022 the company made an earnings per share (EPS) of -$11.52 an increase over its 2021 EPS that were of -$32.33.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$9.78 | -15.09% |
2022 | -$11.52 | -64.36% |
2021 | -$32.33 | 243% |
2020 | -$9.43 | 19.75% |
2019 | -$7.87 | -43.86% |
2018 | -$14.02 | -19.84% |
2017 | -$17.49 | -38.83% |
2016 | -$28.60 | 74.58% |
2015 | -$16.38 | 63.89% |
2014 | -$10.00 | 16.13% |
2013 | -$8.61 | 40.91% |
2012 | -$6.11 | 29.41% |
2011 | -$4.72 | -50% |
2010 | -$9.44 | -27.66% |
2009 | -$13.05 | -11.32% |
2008 | -$14.71 | -7.02% |
2007 | -$15.83 | 46.15% |
2006 | -$10.83 | 50% |
2005 | -$7.22 | -63.38% |
2004 | -$19.71 | 20.34% |
2003 | -$16.38 | -35.87% |
2002 | -$25.54 | 113.95% |
2001 | -$11.94 | -33.85% |
2000 | -$18.05 | 109.68% |
1999 | -$8.61 | -40.38% |
1998 | -$14.44 | 30% |
1997 | -$11.11 | -9.007199254741E+17% |
1996 | $0.0000000000 |